Literature DB >> 20845010

Lymph node retrieval and examination during the implementation of extended lymph node dissection for gastric cancer in a non-specialized western institution.

Marco Catarci1, Leonardo Antonio Montemurro, Antonio Di Cintio, Sabrina Ghinassi, Luigi Coppola, Luigi Pinnarelli, Augusto Belardi, Maurizio Koch, Giovanni Battista Grassi.   

Abstract

The optimal degree of lymph node dissection for gastric cancer is still matter of debate. Particularly, there are serious doubts about the reproducibility of extended lymph node dissection in western surgical units, and no studies to date have investigated factors influencing lymph node retrieval and examination during the learning curve. Univariate and multivariate retrospective analysis of 21 variables were carried out on a prospective series of 313 consecutive resections for gastric cancer performed by ten different surgeons, with lymph node retrieval and analysis performed by ten different pathologists. Endpoints were number of examined lymph nodes per patient, number of cases with inadequate nodal staging (<15 examined lymph nodes) and lymph node ratio (calculated as the absolute ratio between the number of metastatic and the number of examined lymph nodes). The number of examined lymph nodes per patient (mean ± SD 28.3 ± 14.1, median 26, range 2-78) was independently influenced by age, pN status, the type of gastric resection, the degree of lymph node dissection and single pathologist. There were 47 cases (15.0%) with incomplete nodal staging that was independently determined by the degree of lymph node dissection and by the pathologist. Lymph node ratio was independently influenced by the number of metastatic lymph nodes, the disease stage and by the histological subtype of the tumor. The role of an experienced or dedicated pathologist should not be underevaluated in western series when dealing with lymph node retrieval and examination. Lymph node ratio appeared not to be significantly influenced by the number of examined lymph nodes, being independently influenced only by the number of metastatic lymph nodes, the disease stage and by the histological subtype of the tumor. It could be therefore tested as a prognostic factor limiting the stage-migration phenomenon induced by extended lymph node dissection.

Entities:  

Mesh:

Year:  2010        PMID: 20845010     DOI: 10.1007/s13304-010-0017-8

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  29 in total

Review 1.  The difference in gastric cancer between Japan, USA and Europe: what are the facts? what are the suggestions?

Authors:  P A Davis; T Sano
Journal:  Crit Rev Oncol Hematol       Date:  2001-10       Impact factor: 6.312

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  Extended lymph-node dissection for gastric cancer.

Authors:  J J Bonenkamp; J Hermans; M Sasako; C J van de Velde; K Welvaart; I Songun; S Meyer; J T Plukker; P Van Elk; H Obertop; D J Gouma; J J van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus
Journal:  N Engl J Med       Date:  1999-03-25       Impact factor: 91.245

4.  Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases.

Authors:  J R Siewert; R Kestlmeier; R Busch; K Böttcher; J D Roder; J Müller; C Fellbaum; H Höfler
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

5.  Lymph node counts in indians in relation to lymphadenectomy for carcinoma of the oesophagus and stomach.

Authors:  Dhananjaya Sharma; Ashok Thakur; Sarita Toppo; Shiv Kumar Chandrakar
Journal:  Asian J Surg       Date:  2005-04       Impact factor: 2.767

Review 6.  Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification.

Authors:  J Rüdiger Siewert; Marcus Feith; Hubert J Stein
Journal:  J Surg Oncol       Date:  2005-06-01       Impact factor: 3.454

7.  Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy--Japan Clinical Oncology Group study 9501.

Authors:  Takeshi Sano; Mitsuru Sasako; Seiichiro Yamamoto; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

8.  Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.

Authors:  M Degiuli; M Sasako; M Calgaro; M Garino; F Rebecchi; M Mineccia; D Scaglione; D Andreone; A Ponti; F Calvo
Journal:  Eur J Surg Oncol       Date:  2004-04       Impact factor: 4.424

Review 9.  Pancreas-preserving total gastrectomy for proximal gastric cancer.

Authors:  K Maruyama; M Sasako; T Kinoshita; T Sano; H Katai; K Okajima
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

View more
  5 in total

Review 1.  N staging: the role of the pathologist.

Authors:  Costanza De Marco; Alberto Biondi; Riccardo Ricci
Journal:  Transl Gastroenterol Hepatol       Date:  2017-02-20

2.  Long-term results of tailored D(2) lymph node dissection after R(0) surgery for gastric cancer.

Authors:  Marco Catarci; Leonardo Antonio Montemurro; Sabrina Ghinassi; Antonio Di Cintio; Leonardo Leone; Luigi Marino Cosentino; Maria Antonietta Viarengo; Giovanni Battista Grassi
Journal:  Updates Surg       Date:  2011-03-29

3.  Lower serum folate is associated with development and invasiveness of gastric cancer.

Authors:  Teng-Yu Lee; En-Pei Chiang; Yin-Ting Shih; Hsien-Yuan Lane; Jaw-Town Lin; Chun-Ying Wu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

4.  Retrieval of 30 Lymph Nodes Is Mandatory for Selected Stage II Gastric Cancer Patients.

Authors:  Yong-He Chen; Jun Lu; Run-Cong Nie; Dan Liu; Ai-Hong Liu; Zi-Jian Deng; Xi-Jie Chen; Jun Xiang; Ying-Bo Chen; Chang-Ming Huang; Shi Chen; Jun-Sheng Peng
Journal:  Front Oncol       Date:  2021-04-30       Impact factor: 6.244

5.  Pancreatic enzyme supplementation after gastrectomy for gastric cancer: a randomized controlled trial.

Authors:  Marco Catarci; Manuele Berlanda; Giovanni Battista Grassi; Francesco Masedu; Stefano Guadagni
Journal:  Gastric Cancer       Date:  2017-08-14       Impact factor: 7.370

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.